Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.

Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recip...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Lacy, MD, Maguire, J, Barcus, M, Ling, J, Bangs, M, Gramzinski, R, Basri, H, Sismadi, P, Miller, G, Chulay, J, Fryauff, D, Hoffman, S, Baird, J
Формат: Journal article
Хэл сонгох:English
Хэвлэсэн: 2002

Ижил төстэй зүйлс

Ижил төстэй зүйлс